State retention power gated cell
    1.
    发明授权
    State retention power gated cell 有权
    状态保持力门控电池

    公开(公告)号:US08987786B1

    公开(公告)日:2015-03-24

    申请号:US14277804

    申请日:2014-05-15

    摘要: A state retention power gated cell includes a logic cell arranged in two or more rows. The logic cell has an active layer including at least a first well and a second well disposed in first and second rows, respectively. In a normal operation mode, the first well is powered with a first bias voltage, the second well is powered with a second bias voltage, the first power supply line is powered with VDDC, and the second power supply line is powered with VDD. In a standby mode, the first well preferably is powered down, the second well is powered with the second bias voltage, the first power supply line is powered with VDDC, and the second power supply line is powered down.

    摘要翻译: 状态保持功率选通单元包括布置成两行或多行的逻辑单元。 逻辑单元具有分别包括至少第一阱和第二阱的有源层,第一阱和第二阱分别布置在第一和第二行中。 在正常工作模式下,第一个阱由第一偏置电压供电,第二个阱由第二个偏置电压供电,第一个电源线由VDDC供电,第二个电源线由VDD供电。 在待机模式中,第一阱优选地断电,第二阱由第二偏置电压供电,第一电源线由VDDC供电,并且第二电源线断电。

    STATE RETENTION POWER GATED CELL
    2.
    发明申请
    STATE RETENTION POWER GATED CELL 有权
    状态保持电力接通电池

    公开(公告)号:US20150091626A1

    公开(公告)日:2015-04-02

    申请号:US14277804

    申请日:2014-05-15

    IPC分类号: H03K3/012 H03K3/356 H03K19/00

    摘要: A state retention power gated cell includes a logic cell arranged in two or more rows. The logic cell has an active layer including at least a first well and a second well disposed in first and second rows, respectively. In a normal operation mode, the first well is powered with a first bias voltage, the second well is powered with a second bias voltage, the first power supply line is powered with VDDC, and the second power supply line is powered with VDD. In a standby mode, the first well preferably is powered down, the second well is powered with the second bias voltage, the first power supply line is powered with VDDC, and the second power supply line is powered down.

    摘要翻译: 状态保持功率选通单元包括布置成两行或多行的逻辑单元。 逻辑单元具有分别包括至少第一阱和第二阱的有源层,第一阱和第二阱分别布置在第一和第二行中。 在正常工作模式下,第一个阱由第一偏置电压供电,第二个阱由第二个偏置电压供电,第一个电源线由VDDC供电,第二个电源线由VDD供电。 在待机模式中,第一阱优选地断电,第二阱由第二偏置电压供电,第一电源线由VDDC供电,并且第二电源线断电。

    Modified exedins and uses thereof
    3.
    发明授权
    Modified exedins and uses thereof 有权
    改良的exedins及其用途

    公开(公告)号:US08097586B2

    公开(公告)日:2012-01-17

    申请号:US11813917

    申请日:2006-01-10

    IPC分类号: A61K38/00 A23J1/00

    摘要: Novel exendins with modifications at one or more of following positions: 2, 14, 27 or 28 and polyethylene glycol derivatives thereof are provided. These compounds are useful in treating type 2 diabetes as GLP-1 receptor agonists.

    摘要翻译: 提供了在以下一个或多个位置具有修饰的新型毒蜥外泌肽:2,14,27或28及其聚乙二醇衍生物。 这些化合物可用于治疗2型糖尿病作为GLP-1受体激动剂。

    Modified exendins and uses thereof
    5.
    发明授权
    Modified exendins and uses thereof 有权
    改良的exendins及其用途

    公开(公告)号:US08716221B2

    公开(公告)日:2014-05-06

    申请号:US13334912

    申请日:2011-12-22

    IPC分类号: A61K38/00 A61K38/26

    摘要: The present invention discloses a modified exendin or pharmaceutically acceptable salts thereof, wherein the modified exendin comprises an amino acid sequence having at least 90% sequence identity to SEQ ID No. 17 and the amino acid sequence has a higher stability than the non-modified exendin of SEQ ID No. 4. These compounds are useful in treating type 2 diabetes as GLP-1 receptor agonists.

    摘要翻译: 本发明公开了一种修饰的毒蜥外泌肽或其药学上可接受的盐,其中所述修饰的毒蜥外泌肽包含与SEQ ID No.17具有至少90%序列同一性的氨基酸序列,并且所述氨基酸序列具有比未修饰的毒蜥外泌肽更高的稳定性 这些化合物可用于治疗2型糖尿病作为GLP-1受体激动剂。

    Repeater and self-excitation detecting method and system
    7.
    发明授权
    Repeater and self-excitation detecting method and system 失效
    中继器和自激检测方法及系统

    公开(公告)号:US08369773B2

    公开(公告)日:2013-02-05

    申请号:US12673128

    申请日:2008-08-07

    IPC分类号: H04B7/15

    CPC分类号: H04B17/40 H04B7/155

    摘要: The present invention relates to the communication field and provides method and system for detecting repeater self-excitation and the repeater using the method and system. The method includes detecting an output power of an up link; judging whether the detected output power of the up link exceeds a threshold of self-excitation and, if so, adding a numerically-controlled attenuation to the up link accordingly; and judging whether the change in the output power of the up link is equal to that in the numerically-controlled attenuation and, judging whether the repeater is subject to a self-excitation according to the result of judgment regarding the change in the output power of the up link. The repeater self-excitation detecting method has the following advantages: 1. The self-excitation can be detected in time, thus avoiding had effect on the communication system; 2. The devices of repeater can be protected from being burned down; and 3. The cost incurred by the patrol inspection personnel can be reduced.

    摘要翻译: 本发明涉及通信领域,并提供了使用该方法和系统检测中继器自激和中继器的方法和系统。 该方法包括检测上行链路的输出功率; 判断检测到的上行链路的输出功率是否超过自激阈值,如果是,则相应地向上行链路增加数字控制的衰减; 并且判断上行链路的输出功率的变化是否等于数控衰减中的输出功率的变化,并且根据关于输出功率的变化的判断结果判断中继器是否进行自激 向上链接。 中继器自激检测方法具有以下优点:1.可以及时检测自激,避免对通信系统产生影响; 2.中继器的设备可以保护不被烧毁; 3.巡视检查人员的费用可以减少。

    Erythropoietin mimetic peptide derivative and its pharmaceutical salts, the preparation and uses thereof
    8.
    发明授权
    Erythropoietin mimetic peptide derivative and its pharmaceutical salts, the preparation and uses thereof 有权
    红细胞生成素模拟肽衍生物及其药用盐,的制备及应用

    公开(公告)号:US08642545B2

    公开(公告)日:2014-02-04

    申请号:US12747818

    申请日:2008-11-24

    IPC分类号: C07K14/505

    摘要: What is provided is EPO mimetic peptide derivatives defined as formula (I) and their pharmaceutical salts, the preparation thereof, wherein R1, R2, R3, R4, R5, n1, n2 are defined as described in description. A composition comprising of an EPO mimetic peptide derivative defined as formula (I) and its pharmaceutical salt. The uses of the derivatives and their pharmaceutical salts, as well as the uses of the compositions described above in treatment of diseases characterized by a deficiency of EPO or a low or defective red blood cell population. R1—R2—(CH2)n1—R3—(CH2)n2—R4—R5  (I)

    摘要翻译: 提供的定义为式(I)的EPO模拟肽衍生物及其药物盐及其制备方法,其中R1,R2,R3,R4,R5,n1,n2如描述中所述定义。 包含由式(I)定义的EPO模拟肽衍生物及其药物盐的组合物。 衍生物及其药物盐的用途,以及上述组合物在治疗由EPO缺乏或低或有缺陷的红细胞群体特征的疾病的用途中的用途。 R1-R2-(CH2)n1-R3-(CH2)n2-R4-R5(I)

    GLP-1 ANALOGUES AND THEIR PHARMACEUTICAL SALTS AND USES
    9.
    发明申请
    GLP-1 ANALOGUES AND THEIR PHARMACEUTICAL SALTS AND USES 审中-公开
    GLP-1类似物及其药物销售和用途

    公开(公告)号:US20120129768A1

    公开(公告)日:2012-05-24

    申请号:US13388056

    申请日:2010-07-29

    CPC分类号: C07K14/605 A61K38/00

    摘要: This invention discloses GLP-1 analogues and their pharmaceutical salts, wherein the GLP-1 analogue comprises an amino acid sequence of general formula (I), wherein Lys represents a modified lysine with a lipophilic acid. The GLP-1 analogues provided by this invention have the function of human GLP-1, and a longer half-life in vivo compared with the human GLP-1. Uses of such compounds and compositions include treating non-insulin-dependent diabetes, insulin-dependent diabetes, and obesity. (I) X1-X2-Glu-Gly-Thr-Phe-Thr-Ser-Asp-X10-Ser-X12- X13-X14-Glu-X16-X17-Ala-X19-X20-X21-Phe-Ile-X24- Trp-Leu-X27-X28-X29-X30-X31-X32-X33-X34-X35-X36- X37-X38-X39-Lys

    摘要翻译: 本发明公开了GLP-1类似物及其药物盐,其中GLP-1类似物包含通式(I)的氨基酸序列,其中Lys表示具有亲脂性酸的经修饰的赖氨酸。 本发明提供的GLP-1类似物具有人GLP-1的功能,与人GLP-1相比体内的半衰期更长。 这些化合物和组合物的用途包括治疗非胰岛素依赖性糖尿病,胰岛素依赖型糖尿病和肥胖症。 (I)X1-X2-Glu-Gly-Thr-Phe-Thr-Ser-Asp-X10-Ser-X12-X13-X14-Glu-X16-X17-Ala-X19-X20-X21-Ph​​e-Ile-X24 - Trp-Leu-X27-X28-X29-X30-X31-X32-X33-X34-X35-X36-X37-X38-X39-Lys

    COMPENSATING METHOD FOR CAPACITY OF RADIO FREQUENCY MODULE AND A RADIO FREQUENCY MODULE
    10.
    发明申请
    COMPENSATING METHOD FOR CAPACITY OF RADIO FREQUENCY MODULE AND A RADIO FREQUENCY MODULE 失效
    无线电频率模块和无线电频率模块的容量补偿方法

    公开(公告)号:US20100240325A1

    公开(公告)日:2010-09-23

    申请号:US12738645

    申请日:2008-07-01

    IPC分类号: H04B1/40

    CPC分类号: H04W52/52

    摘要: A compensation method for radio frequency module performance, it is adding a module monitoring circuit and a radio frequency power detection circuit to an existing radio frequency module, meanwhile replacing an existing hardware compensation circuit with a radio frequency digital controlled attenuator. The method replaces hardware method by a method of combining software of the module monitoring circuit and hardware such as module monitoring circuit, radio frequency digital controlled attenuator and radio frequency power detection circuit, as well as intelligently compensates the radio frequency module by using data obtained by predefined table or formula/algorithm, so as to adjust each characteristic index of the device accurately and easily, thus to improve performance of the radio frequency module and further meet the requirement of working stability of the radio frequency module. The present invention further provides a radio frequency module improved by such method. As such radio frequency module can be automatically debugged and tested by tools such as computer, so production efficiency will be improved.

    摘要翻译: 一种射频模块性能补偿方法,将现有射频模块的模块监控电路和射频功率检测电路相加,同时用射频数字控制衰减器代替现有的硬件补偿电路。 该方法通过组合模块监控电路的软件和模块监控电路,射频数字受控衰减器和射频功率检测电路等硬件的方法代替硬件方法,并通过使用数据获得的数据智能地补偿射频模块 预定义表或公式/算法,从而准确,轻松地调整设备的每个特征指标,从而提高射频模块的性能,进一步满足射频模块工作稳定性要求。 本发明还提供一种通过这种方法改进的射频模块。 由于这样的射频模块可以通过诸如计算机的工具进行自动调试和测试,因此生产效率将得到提高。